Related Experiment Video
Updated: Jul 5, 2026

13:13
Biochemical Measurement of Neonatal Hypoxia
Published on: August 24, 2011
Biochemical markers predictive of preterm delivery
1Division of Maternal-Fetal Medicine Department of Obstetrics and Gynecology New York Hospital-Cornell Medical Center 525 E. 68th St. J-130 New York New York 10021 USA.
Infectious Diseases in Obstetrics and Gynecology
|January 1, 1997
Summary
Biochemical markers offer insights into the complex causes of preterm delivery, aiding in tailored treatments. Cervical ultrasound measurements are a more accessible method for predicting preterm birth currently.
Area of Science:
- Obstetrics and Gynecology
- Perinatal Medicine
- Biochemical Markers
Background:
- Preterm delivery is a major global cause of infant illness and death.
- Current understanding of preterm birth pathophysiology remains incomplete.
- Existing treatments for preterm delivery demonstrate limited effectiveness.
Purpose of the Study:
- To evaluate the utility of biochemical markers in predicting preterm delivery.
- To explore the potential of biochemical markers in understanding preterm birth etiologies.
- To assess alternative methods for preterm birth prediction.
Main Methods:
- Development and application of biochemical markers for preterm delivery prediction.
- Analysis of marker performance in identifying patients at risk for preterm labor.
- Comparison of biochemical markers with ultrasound cervical measurements.
Main Results:
- Biochemical markers provide satisfactory, though not perfect, prediction of preterm labor.
- These markers have illuminated the diverse causes of preterm delivery.
- Ultrasound cervical measurements are identified as a faster, more cost-effective prediction method.
Conclusions:
- Biochemical markers offer valuable insights into the complex pathophysiology of preterm delivery.
- Understanding specific etiologies is crucial for developing targeted and effective therapies.
- Cervical ultrasound is currently a more practical tool for predicting preterm birth.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

